Skip links

Archive

New Funding Boosts URMC Biotech Start-Up for Neurological Disorders

New Funding Boosts URMC Biotech Start-Up for Neurological Disorders

in

Oscine Therapeutics, a new biotechnology company based on discoveries made and developed at the University of Rochester Medical Center (URMC) has received a significant multi-year investment to support both research and development of cell-based therapies for neurological disorders. The funding represents the largest-ever investment in